Skip to main content

Table 2 Cardiac parameters calculated from Magnetic Resonance exams performed through the study

From: Delayed administration of allogeneic cardiac stem cell therapy for acute myocardial infarction could ameliorate adverse remodeling: experimental study in swine

  CON group D7 group D0 group
  Baseline (preinfarction) Day 0 preinjection 1 week 10 weeks Baseline (preinfarction) Day 0 preinjection 1 week 10 weeks Baseline (preinfarction) 1 week 10 weeks
Weight (kg) 32.5 ± 1.87 33.8 ± 1.33 33.0 ± 1.67 39.17 ± 2.71 30.67 ± 1.97 31.00 ± 3.80 30.33 ± 2.73 41.33 ± 5.01 31.60 ± 2.07 34.60 ± 1.67 42.60 ± 4.98
EF (%) 51.57 ± 7.48 38.22 ± 10.4 41.03 ± 5.66 41.70 ± 10.88 51.08 ± 7.68 41.07 ± 7.50 42.17 ± 5.70 45.93 ± 6.15 54.24 ± 8.63 36.58 ± 8.97 42.58 ± 8.80
EDVi (mL/m2) 82.61 ± 18.36 106.24 ± 10.96 110.16 ± 11.49 121.70 ± 26.09* 79.18 ± 13.20 97.86 ± 13.00 106.57 ± 8.42 98.71 ± 8.30* 79.95 ± 7.59 101.65 ± 22.02 106.04 ± 7.26
ESVi (mL/m2) 39.97 ± 9.47 66.1 ± 15.74 65.09 ± 10.39 72.72 ± 27.18 38.92 ± 9.65 57.60 ± 9.85 61.64 ± 8.00 53.45 ± 8.01 36.94 ± 9.58 65.28 ± 19.55 61.18 ± 12.08
% Infarct n/a 17.20 ± 5.54 11.33 ± 2.94 7.50 ± 2.07 n/a 16.33 ± 3.61 13.33 ± 4.88 10.00 ± 4.29 n/a 17.00 ± 3.46 9.40 ± 2.79
Infarct mass (g) n/a 13.28 ± 4.96 7.46 ± 1.92 5.25 ± 1.32 n/a 10.49 ± 2.65 7.95 ± 2.36 6.20 ± 2.45 n/a 12.16 ± 3.88 7.03 ± 2.29
  1. Data presented as mean ± standard deviation. EF: Ejection fraction. EDVi: End diastolic volume indexed to body surface area. ESVi: End systolic volume indexed to body surface area. n/a: Not applicable. * P < 0.05 (Mann Whitney U test. Intergroup comparisons at each time point)